British pharmaceutical giant GSK has announced its agreement to acquire Boston-based biotechnology firm IDRx for up to $1.15 billion, marking a significant expansion...
By 193cc Agency CouncilJanuary 13, 2025Zhu Baoguo, the chairman of Shenzhen-based Joincare Pharmaceutical Group Industry, is a name synonymous with determination, innovation, and business acumen. His journey from...
By 193cc World's BillionairesJanuary 9, 2025Zhao Yan, the chairman and CEO of Shanghai-listed Bloomage Biotechnology, is a name synonymous with innovation and versatility in the biotechnology industry. Known...
By 193cc World's BillionairesJanuary 5, 2025Li Ge, a pioneering figure in the global biotech and pharmaceutical industries, has made an indelible mark as the chairman and CEO of...
By 193cc World's BillionairesJanuary 4, 2025